Details

Autor(en) / Beteiligte

• Zubarevich, Alina
• Zhigalov, Konstantin
• Szczechowicz, Marcin
• Thielmann, Matthias
• Rabis, Marco
• Van den Eynde, Jef
• Sá, Michel Pompeu B. O.
• Weissenberger, Wilko
• Kadyraliev, Bakytbek
• Enginoev, Soslan
• Jánosi, Rolf Alexander
• Lind, Alexander
• Rassaf, Tienush
• Schmack, Bastian
• Ruhparwar, Arjang
• Weymann, Alexander
• Wendt, Daniel

Titel

Simultaneous transaortic transcatheter aortic valve implantation and off‐pump coronary artery bypass: An effective hybrid approach

Ist Teil von

• Journal of cardiac surgery, 2021-04, Vol.36 (4), p.1226-1231

Ort / Verlag

United States

Erscheinungsjahr

2021

Quelle

Wiley-Blackwell Full Collection

Beschreibungen/Notizen

• Introduction Transcatheter aortic valve implantation (TAVI) techniques are increasingly being adopted into clinical routine for various risk groups. Coronary artery disease (CAD) is seen in up to 75% of patients with severe aortic valve stenosis (AS) presenting with typical angina pectoris. Due to high mortality rates and procedural complications in these patients, a hybrid concept of simultaneous transaortic TAVI and off‐pump coronary artery bypass (OPCAB) can be a feasible treatment option. Methods Between April 2014 and July 2020, 10 consecutive high‐risk patients underwent concomitant transaortic TAVI and OPCAB at our institution. All indications were discussed in Heart Team and decisions were made based on patients' comorbidities and complexity of CAD. The study endpoints were 30‐day mortality, device success, and development of postoperative adverse events defined by the Valve Academic Research Consorium. Results The mean age of the patients was 77.9 ± 7.1 years old. All patients presented with multiple comorbidities (mean logistic EuroSCORE 26.5 ± 12.3%, median EuroSCORE II 5.13% [interquartile range 4.2–9.5], mean STS‐Score 6.04 ± 1.6%). Five patients (50%) presented with porcelain aorta. No conversion to conventional procedures was needed. 30‐day mortality occurred in one patient (10%). Complete revascularization was achieved in seven (70%) of the patients. Device success rate was 100%. No paravalvular leakage was detected. No stroke, myocardial infarction or vascular complications were observed. Conclusions A hybrid approach combining transaortic TAVI and OPCAB might be a safe and feasible method of treatment in high‐risk patients presenting with severe AS and CAD who are not eligible for conventional surgical or interventional solutions.